Home -> Law Blog Directory -> Patent Law Blogs -> Philip Brooks’ Patent Infringement Updates
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Patent Law
: Philip Brooks’ Patent Infringement UpdatesOral Arguments Completed in PTO v. GSK, Tafas
By Philip Brooks
Gene Quinn of IPWatchdog "attended the oral arguments this morning at the United States Court of Appeals for the Federal Circuit regarding the matter of the United States Patent & Trademark Office v. Tafas, the appeal of the claims and continuations rules promulgated by the USPTO back in August of 2007, which were preliminarily enjoined and ultimately permanently enjoined by Judge Cacheris of the United States District Court for the Eastern District of Virginia."
In summary Gene writes:
It is hard to imagine that GlaxoSmithKline and Dr. Tafas could have drawn a better three judge panel than they did for this appeal of Judge Cacheris? ruling. The judges assigned to the panel hearing the case were Judges Rader, Bryson and Prost, who took turns laying it on the government USPTO General Counsel Toupin. It is hard to imagine based on the barrage of questions thrown at Toupin that this panel is going to do anything other than affirm Judge Cacheris? decision and rule that the claims and continuations rules were beyond the authority of the Patent Office and cannot be implemented.
Read the full detailed post here.
Full post as published by Philip Brooks’ Patent Infringement Updates on December 05, 2008 (boomark / email).
Oral HRT
More Than Doubles the Risk of Blood Clots
Blood Clots
Associated with Oral Contraceptives Yaz and Yasmin
Generic Versions
Barr Pharmaceuticals to pay $5.9 million settlement for blocking the sale of oral contraceptives.
Oral Sodium Phosphate
or OSP has allegedly been recalled for acute kidney injury and kidney failure.

Feb. 8: oral arguments in Tafas v. Dudas
Oral Arguments in Tafas v. Dudas
Tafas v. Dudas Oral Arguments Completed at the CAFC
Scheduled CAFC Oral Arguments in USPTO v. GSK & Tafas - December 5, 2008.








